Elon Musk confirmed that he is going to Germany to review Tesla’s effort to build a new kind of vaccine printer with Curevac and the progress at Gigafactory Berlin.
Earlier this year, Musk announced that Tesla has become the manufacturing partner for biotech firm CureVac who is working on a COVID-19 vaccine based on their RNA technology.
The CEO announced that Tesla would be “building RNA micro-factories for CureVac,” a Germany-based company.
It was surprising since it’s a completely different sector than electric vehicles or renewable energy.
But as we previously reported, Tesla had been working with CureVac since last year — prior to the global COVID-19 pandemic.
Now Musk says that he is going to Germany this week to review the project, along with Tesla’s progress at Gigafactory Berlin.